Literature DB >> 34741979

Relationships between constitutive and acute gene regulation, and physiological and behavioral responses, mediated by the neuropeptide PACAP.

Dana Bakalar1, Sean Sweat1, Gunner Drossel1, Sunny Z Jiang1, Babru B Samal1, Nikolas Stroth1, Wenqin Xu1, Limei Zhang2, Haiying Zhang1, Lee E Eiden3.   

Abstract

Since the advent of gene knock-out technology in 1987, insight into the role(s) of neuropeptides in centrally- and peripherally-mediated physiological regulation has been gleaned by examining altered physiological functioning in mammals, predominantly mice, after genetic editing to produce animals deficient in neuropeptides or their cognate G-protein coupled receptors (GPCRs). These results have complemented experiments involving infusion of neuropeptide agonists or antagonists systemically or into specific brain regions. Effects of gene loss are often interpreted as indicating that the peptide and its receptor(s) are required for the physiological or behavioral responses elicited in wild-type mice at the time of experimental examination. These interpretations presume that peptide/peptide receptor gene deletion affects only the expression of the peptide/receptor itself, and therefore impacts physiological events only at the time at which the experiment is conducted. A way to support 'real-time' interpretations of neuropeptide gene knock-out is to demonstrate that the wild-type transcriptome, except for the deliberately deleted gene(s), in tissues of interest, is preserved in the knock-out mouse. Here, we show that there is a cohort of genes (constitutively PACAP-Regulated Genes, or cPRGs) whose basal expression is affected by constitutive knock-out of the Adcyap1 gene in C57Bl6/N mice, and additional genes whose expression in response to physiological challenge, in adults, is altered or impaired in the absence of PACAP expression (acutely PACAP-Regulated Genes, or aPRGs). Distinguishing constitutive and acute transcriptomic effects of neuropeptide deficiency on physiological function and behavior in mice reveals alternative mechanisms of action, and changing functions of neuropeptides, throughout the lifespan.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neuropeptide; PACAP; Stress responding; Transcriptomics

Mesh:

Substances:

Year:  2021        PMID: 34741979      PMCID: PMC8900973          DOI: 10.1016/j.psyneuen.2021.105447

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  68 in total

Review 1.  Neuropeptides--an overview.

Authors:  T Hökfelt; C Broberger; Z Q Xu; V Sergeyev; R Ubink; M Diez
Journal:  Neuropharmacology       Date:  2000-06-08       Impact factor: 5.250

2.  Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain.

Authors:  Y Skoglösa; N Takei; D Lindholm
Journal:  Brain Res Mol Brain Res       Date:  1999-02-19

Review 3.  Neurotrophic effects of PACAP in the cerebellar cortex.

Authors:  Béatrice Botia; Magali Basille; Aurélie Allais; Emilie Raoult; Anthony Falluel-Morel; Ludovic Galas; Valérie Jolivel; Olivier Wurtz; Hitoshi Komuro; Alain Fournier; Hubert Vaudry; Delphine Burel; Bruno J Gonzalez; David Vaudry
Journal:  Peptides       Date:  2007-05-01       Impact factor: 3.750

4.  Pharmacological characterization of human and murine neuropeptide s receptor variants.

Authors:  Rainer K Reinscheid; Yan-Ling Xu; Naoe Okamura; Joanne Zeng; Shinjae Chung; Rama Pai; Zhiwei Wang; Olivier Civelli
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

5.  Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.

Authors:  Seiji Shioda; Hirokazu Ohtaki; Tomoya Nakamachi; Kenji Dohi; Jun Watanabe; Shigeo Nakajo; Satoru Arata; Shinji Kitamura; Hiromi Okuda; Fumiko Takenoya; Yoshitaka Kitamura
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

6.  Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study.

Authors:  Jens Hannibal
Journal:  J Comp Neurol       Date:  2002-11-25       Impact factor: 3.215

7.  Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla.

Authors:  K Moller; F Sundler
Journal:  Regul Pept       Date:  1996-07-05

8.  Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons.

Authors:  Béatrice Botia; Damien Seyer; Aurélia Ravni; Magalie Bénard; Anthony Falluel-Morel; Pascal Cosette; Thierry Jouenne; Alain Fournier; Hubert Vaudry; Bruno J Gonzalez; David Vaudry
Journal:  J Mol Neurosci       Date:  2008-05-20       Impact factor: 3.444

9.  Neuronal markers, peptides and enzymes in nerves and chromaffin cells in the rat adrenal medulla during postnatal development.

Authors:  H Holgert; A Dagerlind; T Hökfelt; H Lagercrantz
Journal:  Brain Res Dev Brain Res       Date:  1994-11-18

10.  Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals.

Authors:  X Guo; A R Wakade
Journal:  J Physiol       Date:  1994-03-15       Impact factor: 5.182

View more
  1 in total

1.  Shorebirds' Longer Migratory Distances Are Associated With Larger ADCYAP1 Microsatellites and Greater Morphological Complexity of Hippocampal Astrocytes.

Authors:  Diego de Almeida Miranda; Juliana Araripe; Nara G de Morais Magalhães; Lucas Silva de Siqueira; Cintya Castro de Abreu; Patrick Douglas Corrêa Pereira; Ediely Pereira Henrique; Pedro Arthur Campos da Silva Chira; Mauro A D de Melo; Péricles Sena do Rêgo; Daniel Guerreiro Diniz; David Francis Sherry; Cristovam W P Diniz; Cristovam Guerreiro-Diniz
Journal:  Front Psychol       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.